Concurrent Naloxone Dispensing Among Individuals with High-Risk Opioid Prescriptions, USA, 2015-2019

J Gen Intern Med. 2021 Oct;36(10):3254-3256. doi: 10.1007/s11606-021-06662-3. Epub 2021 Mar 9.

Authors

Gery P Guy Jr¹, Andrea E Strahan², Tamara Haegerich², Jan L Losby², Kathleen Ragan², Mary E Evans², Christopher M Jones³

Affiliations

¹ Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. irm2@cdc.gov.
² Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
³ National Center for Injury Prevention and Control, CDC, Atlanta, USA.

No abstract available

MeSH terms

Analgesics, Opioid / therapeutic use
Drug Overdose* / drug therapy
Drug Overdose* / epidemiology
Drug Overdose* / prevention & control
Drug Prescriptions
Humans
Naloxone / therapeutic use
Narcotic Antagonists / therapeutic use
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / epidemiology
Prescriptions

Substances

Analgesics, Opioid
Narcotic Antagonists
Naloxone